Schedule 13G ownership disclosure

Lexeo Therapeutics Inc

Common Stock · CUSIP: 52886X107

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • JANUS HENDERSON GROUP PLC

    Shares: 3,684,383 · Class: 11.1%

  • Janus Henderson Biotech Innovation Master Fund Ltd

    Shares: 2,041,481 · Class: 6.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000249
Form type
SCHEDULE 13G/A
Filer
Janus Henderson Group Ltd.
CIK
CIK 1274173
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub